Meeder Advisory Services’s AbbVie ABBV Stock Holding History

Meeder Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.3M	Buy	51,790 +1,860	+4%	+$413K	0.47%	32
2025 Q4	$11.4M	Buy	49,930 +1,792	+4%	+$408K	0.49%	35
2025 Q3	$11.1M	Buy	48,138 +3,268	+7%	+$665K	0.52%	34
2025 Q2	$8.33M	Buy	44,870 +1,511	+3%	+$281K	0.43%	38
2025 Q1	$9.08M	Buy	43,359 +4,375	+11%	+$851K	0.54%	34
2024 Q4	$6.93M	Sell	38,984 -138	-0.4%	-$25.4K	0.43%	38
2024 Q3	$7.73M	Buy	39,122 +1,173	+3%	+$219K	0.5%	33
2024 Q2	$6.51M	Buy	37,949 +8,353	+28%	+$1.38M	0.46%	35
2024 Q1	$5.39M	Buy	29,596 +1,006	+4%	+$173K	0.55%	29
2023 Q4	$4.43M	Buy	28,590 +546	+2%	+$79.6K	0.51%	32
2023 Q3	$4.18M	Sell	28,044 -3,978	-12%	-$584K	0.53%	34
2023 Q2	$4.31M	Sell	32,022 -3,064	-9%	-$449K	0.46%	38
2023 Q1	$5.59M	Buy	35,086 +2,441	+7%	+$373K	0.64%	26
2022 Q4	$5.28M	Buy	+32,645	New	+$5.01M	0.67%	26

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Meeder Advisory Services's ABBV Position: Q1 2026 in Review

Meeder Advisory Services increased its AbbVie (ABBV) stake by 3.7% in Q1 2026, buying an estimated $413K and bringing the position to 51,790 shares worth $11.3M. The position accounts for 0.47% of the portfolio, ranked #32.

Meeder Advisory Services first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. The position peaked at $11.4M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Meeder Advisory Services held 51,790 shares of AbbVie worth $11.3M as of Q1 2026.
Meeder Advisory Services bought 1,860 AbbVie shares in Q1 2026, an estimated $413K.
AbbVie made up 0.47% of Meeder Advisory Services's portfolio in Q1 2026, its #32 holding.
Meeder Advisory Services first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
Meeder Advisory Services's AbbVie position peaked at $11.4M in Q4 2025.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Meeder Advisory Services's 13F filing for Q1 2026, filed 7 May 2026.